Research ExplorerPublicationsMonoubiquitination of histone H2B – a potential new target i...

Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors.

Standard

Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors. / Oing, Christoph; Dyshlovoy, Sergey; Burandt, Eike; Amsberg, Gunhild Von; Honecker, Friedemann; Bokemeyer, Carsten; Rothkamm, Kai; Mansour, Wael Y.

In: ONCOL RES TREAT, Vol. 40, 2017, p. 95-96.

Research output: SCORING: Contribution to journal › Conference abstract in journal › Research › peer-review

Harvard

Oing, C, Dyshlovoy, S, Burandt, E, Amsberg, GV, Honecker, F, Bokemeyer, C, Rothkamm, K & Mansour, WY 2017, 'Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors.', ONCOL RES TREAT, vol. 40, pp. 95-96. https://doi.org/10.13140/rg.2.2.32845.13280

APA

Oing, C., Dyshlovoy, S., Burandt, E., Amsberg, G. V., Honecker, F., Bokemeyer, C., Rothkamm, K., & Mansour, W. Y. (2017). Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors. ONCOL RES TREAT, 40, 95-96. https://doi.org/10.13140/rg.2.2.32845.13280

Vancouver

Oing C, Dyshlovoy S, Burandt E, Amsberg GV, Honecker F, Bokemeyer C et al. Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors. ONCOL RES TREAT. 2017;40:95-96. https://doi.org/10.13140/rg.2.2.32845.13280

Bibtex

@article{e9b879d8fbfc4fb79de276095b09ab8a,
title = "Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors.",
author = "Christoph Oing and Sergey Dyshlovoy and Eike Burandt and Amsberg, {Gunhild Von} and Friedemann Honecker and Carsten Bokemeyer and Kai Rothkamm and Mansour, {Wael Y}",
year = "2017",
doi = "10.13140/rg.2.2.32845.13280",
language = "English",
volume = "40",
pages = "95--96",
journal = "ONCOL RES TREAT",
issn = "2296-5270",
publisher = "S. Karger AG",

}

RIS

TY - JOUR

T1 - Monoubiquitination of histone H2B – a potential new target in treatment resistant germ cell tumors.

AU - Oing, Christoph

AU - Dyshlovoy, Sergey

AU - Burandt, Eike

AU - Amsberg, Gunhild Von

AU - Honecker, Friedemann

AU - Bokemeyer, Carsten

AU - Rothkamm, Kai

AU - Mansour, Wael Y

PY - 2017

Y1 - 2017

U2 - 10.13140/rg.2.2.32845.13280

DO - 10.13140/rg.2.2.32845.13280

M3 - Conference abstract in journal

VL - 40

SP - 95

EP - 96

JO - ONCOL RES TREAT

JF - ONCOL RES TREAT

SN - 2296-5270

ER -